Last reviewed · How we verify
Realgar Indigo naturalis formula
Realgar Indigo naturalis formula is a Small molecule drug developed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. It is currently FDA-approved. Also known as: RIF.
At a glance
| Generic name | Realgar Indigo naturalis formula |
|---|---|
| Also known as | RIF |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study (PHASE4)
- Optimum Induction Therapy of Low-risk APL (NA)
- Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children (PHASE2)
- South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol (PHASE4)
- A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia (PHASE4)
- Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid (PHASE1)
- Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) (PHASE3)
- Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Realgar Indigo naturalis formula CI brief — competitive landscape report
- Realgar Indigo naturalis formula updates RSS · CI watch RSS
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University portfolio CI
Frequently asked questions about Realgar Indigo naturalis formula
What is Realgar Indigo naturalis formula?
Realgar Indigo naturalis formula is a Small molecule drug developed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University.
Who makes Realgar Indigo naturalis formula?
Realgar Indigo naturalis formula is developed and marketed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (see full Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University pipeline at /company/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university).
Is Realgar Indigo naturalis formula also known as anything else?
Realgar Indigo naturalis formula is also known as RIF.
What development phase is Realgar Indigo naturalis formula in?
Realgar Indigo naturalis formula is FDA-approved (marketed).
Related
- Manufacturer: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — full pipeline
- Also known as: RIF
- Compare: Realgar Indigo naturalis formula vs similar drugs
- Pricing: Realgar Indigo naturalis formula cost, discount & access